Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-08-14

Clinical Trial Update: Placebo Versus Oxandrolone Supplementation in Trauma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing placebo to oxandrolone supplementation in trauma patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxandrolone (Oxandrolone)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Trauma Injury | Phase 3 | Status: WITHDRAWN